Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV… Read more
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) - Total Assets
Latest total assets as of September 2025: TL17.28 Billion TRY
Based on the latest financial reports, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) holds total assets worth TL17.28 Billion TRY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Total Assets Trend (2018–2024)
This chart illustrates how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Asset Composition Analysis
Current Asset Composition (December 2024)
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's total assets of TL17.28 Billion consist of 47.1% current assets and 52.9% non-current assets.
| Asset Category | Amount (TRY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | TL0.00 | 4.4% |
| Accounts Receivable | TL1.64 Billion | 13.3% |
| Inventory | TL1.07 Billion | 8.7% |
| Property, Plant & Equipment | TL0.00 | 0.0% |
| Intangible Assets | TL963.44 Million | 7.8% |
| Goodwill | TL0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's current assets represent 47.1% of total assets in 2024, a decrease from 64.7% in 2018.
- Cash Position: Cash and equivalents constituted 4.4% of total assets in 2024, up from 1.4% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 13.3% of total assets.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Competitors by Total Assets
Key competitors of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp Preferred
KO:000105
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma
KO:000220
|
Korea | ₩202.42 Billion |
|
Ildong Holdings Co Ltd
KO:000230
|
Korea | ₩813.62 Billion |
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS generates 1.20x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS generates $ 1.21 in net profit.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.35 | 1.56 | 2.43 |
| Quick Ratio | 1.06 | 1.24 | 1.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | TL2.22 Billion | TL 1.74 Billion | TL 827.43 Million |
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Advanced Valuation Insights
This section examines the relationship between Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.72 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 10.6% |
| Total Assets | TL12.31 Billion |
| Market Capitalization | $69.84 Million USD |
Valuation Analysis
Below Book Valuation: The market values Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's assets grew by 10.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2018–2024)
The table below shows the annual total assets of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | TL12.31 Billion | +10.56% |
| 2023-12-31 | TL11.13 Billion | +202.38% |
| 2022-12-31 | TL3.68 Billion | +73.75% |
| 2021-12-31 | TL2.12 Billion | +96.56% |
| 2020-12-31 | TL1.08 Billion | +92.46% |
| 2019-12-31 | TL560.23 Million | +35.78% |
| 2018-12-31 | TL412.62 Million | -- |